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Still using MS Excel? Implementation of the WHO Go.Data
software for the COVID-19 contact tracing
In the fight against the current epidemic of COVID-19, contact trac-
ing has been used with success in China, as part of a series of con-
tainment efforts.1 Historically, data collection has been done
through paper forms and, over time, this data collection has been
digitalized, usually using the tools at hand, which are typically
spreadsheets and custom-made databases, and in some cases, spe-
cialized software.2 Throughout the world, many agents, from
regional public health agencies to hospitals of all levels, have to
choose a platform to record cases, determine exposures, register
contacts, and manage their follow-up assessments, that is, document
all the events in the chains of transmission. Although in small out-
breaks the management of this information is not overwhelming,
and spreadsheets or small ad-hoc databases can be used, in an out-
break of the scale of COVID-19, with a high number of cases and
around 36 contacts for each one,3 these traditional solutions may not
be scalable to the required levels. Needless to say, the speed and
TABLE 1 Relevant Go.Data characteristics in the follow-up of COVID-19 cases in the HCB
Element Features
Outbreaks The current Go.Data build includes preloaded outbreak templates for the First Few COVID-19 X cases and contacts
transmission investigation protocol (FFX) for COVID-19, as suggested by WHO.7
In general, several outbreaks can be defined, but the “active” outbreak is followed up.
Cases Cases defined are defined through web forms. They can also be imported/exported through MS Excel files and other
formats or in the native “json” Go.Data format, which is an open standard for exchange information.
Cases can be grouped into exposures, clusters, events, and assigned to locations, and users can even add information on the
development of medical tests and assign levels of case confirmation (suspected, confirmed).
Adding contacts and defining a common exposure is easy and can be done individually with forms or through spreadsheet
imports.
Contacts Go.Data allows saving personal data and generating follow-ups that can be assigned to a team of contact tracers with preset,
standard, forms for this. The management of all pending follow-ups can be done through a visual dashboard.
A very useful feature is that contacts can be converted into a case through a single click, safely managing the exchange of
information and recording it. These transitions can be monitored through the transmission chains.
Users The platform allows to create multiple users with different profiles, which can safely work simultaneously updating data,
tracing contacts, and exploiting epidemiological information.
The default user types include contact tracers, contact tracer coordinators, epidemiologist, system administration, and many
others.




Immediately after login, the user can see a visual dashboard which includes epidemic visualizations and different elements to
inform the user of the status of pending tasks.
Besides bar charts, the platform has a built-in map of cases (using WHO map server) and some transmission network
visualization capabilities.




Secure access control through an Internet browser. Users are required to login at the beginning of every session.
Automatic backups and safe restoration. Information exchange through standard protocols and
Possibility of synchronization with other servers at a lower level (clients), which can access part of the information or at a
higher level (mainstream) that collects information from various Go.Data servers.
Cases and Contact data can be downloaded in several formats and protected by a password.
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effectiveness of contact tracking are critical elements for this tool to help
contain the COVID-19 epidemic.4
The objective of this Correspondence is to provide a quick
appraisal of the Go.Data software,5 developed and recommended by
the World Health Organization (WHO) for the investigation and moni-
toring of epidemic outbreaks. With this, we want to encourage all
health care agents who are in charge of contact tracing and are using
solutions based on spreadsheets, which are particularly subject to data
loss and inadvertent errors in formulas,6 to use it. It should be remem-
bered that these tools are not just databases, although they contain
tables and can give the impression of ease.
The Hospital Clínic de Barcelona (HCB) is a third-level university
hospital, designated as the reference hospital in Catalonia for COVID-
19. The initial objective of the implementation of the Go.Data plat-
form was to perform the follow-up of patients who are contacts, and
subsequently, it has also been extended to the follow-up of health
care workers. Our overall impression is that this tool fits our needs
reasonably well and has been used seamlessly by a number of users
for the ongoing epidemic, although it may have to be integrated with
the hospital information systems in the future given the large number
of data that has to be entered manually into the platform.
Table 1 lists some of the more useful features of Go.Data for con-
tact tracing. Note that these constitute only a part of the software
capabilities, which allows for additional settings which can be used to
produce detailed epidemiological data. Despite this wide functionality,
we found the maintenance to be simple, not requiring computer skills
beyond an advanced user level. Even its installation is simple when
used on a single computer, which still allows for simultaneous use by
several users with different roles over a local network. The platform,
which is distributed as MS Windows, Mac OSX, and GNU/Linux bina-
ries, also has a mobile app (which we have not yet used or tested).
Go.Data is distributed using the GPL v3 license, which means it
can be used, modified, and redistributed for free. Although this is not
critical for the present outbreak, it may help at developing client appli-
cations which interact with the platform through the API. The plat-
form is multilingual (currently English, Spanish, French, and
Portuguese) and although some translations are missing, they can be
incorporated within the platform, together with new languages.
In conclusion, Go.Data is an excellent choice for centralizing the
documentation of contact tracing activities and a viable alternative to
health agents who rely on spreadsheets for data collection, and as a
database substitute.
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